Letter to the editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus
M. Morfini,
M. Morfini
Hematology Department and Hemophilia Center
Search for more papers by this author G. Longo,
G. Longo
Hematology Department and Hemophilia Center
Search for more papers by this author P. Rossi Ferrini,
P. Rossi Ferrini
Hematology Department and Hemophilia Center
Search for more papers by this author A. Azzi,
A. Azzi
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author C. Zakrewska,
C. Zakrewska
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author S. Ciappi,
S. Ciappi
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author P. Kolumban,
P. Kolumban
Blood Bank and Hemophilia Center Tirgu-Mures, Rumania
Search for more papers by this author
M. Morfini,
M. Morfini
Hematology Department and Hemophilia Center
Search for more papers by this author G. Longo,
G. Longo
Hematology Department and Hemophilia Center
Search for more papers by this author P. Rossi Ferrini,
P. Rossi Ferrini
Hematology Department and Hemophilia Center
Search for more papers by this author A. Azzi,
A. Azzi
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author C. Zakrewska,
C. Zakrewska
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author S. Ciappi,
S. Ciappi
Microbiology Institute University of Florence Florence, Italy
Search for more papers by this author P. Kolumban,
P. Kolumban
Blood Bank and Hemophilia Center Tirgu-Mures, Rumania
Search for more papers by this author
First published: February 1992
No abstract is available for this article.
References
- 1
Frickhofen N,
Abkowitz JL,
Safford M,
Berry JM,
Antunez-De-mayolo J,
Astrow A,
Cohen R,
Halperin I,
King L,
Mintzer D,
Cohen B,
Young NS:
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (hIV-1): A treatable cause of anemia in AIDS.
Ann Intern Med
113:
926–933,
1990.
- 2
Foreman NK,
Oakhill A,
Caul EO:
Parvovirus-Associated thrombocytopenic purpura.
Lancet
2:
279–80,
1988.
- 3
Kurtzman GJ,
Ozawa K,
Cohen KB,
Hanson G and
Young NS:
Chronic bone marrow failure due to persistent B19 parvovirus infection.
N Engl J Med
317:
287–294,
1987.
- 4
Azzi A,
Macchia PA,
Favre N,
Zakrzewska K,
Bartolomei Corsi O:
Aplastic crisis caused by B19 parvovirus infection in a child during induction therapy for acute lymphoblastic leukemia.
Haematologica
74:
17–21,
1989.
- 5
Frickhofen N,
Young NS:
Persistent parvovirus B19 infections in humans.
Microb Pathog
7:
319–327,
1989.
- 6
Bartolomei Corsi O,
Azzi A,
Morfini M,
Fanci R,
Rossi Ferrini P:
Human parvovirus infection in hemophiliacs first infused with treated clotting factor concentrates.
J Med Virol
25:
165–170,
1988.
- 7
Mortimer PP:
Transmission of serum parvovirus-Like virus by clottingfactor concentrates.
Lancet
2:
482–484,
1983.
- 8
Williams MD,
Cohen B,
Beddal AC,
Pasi K,
Mortimer PP,
Hill FGH:
Transmission of human parvovirus B19 by coagulation factor concentrates.
Vox Sang
58:
177–181,
1990.
